drugset / Trial / NCT05648526

Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10

NCT05648526 ↗

Completed 42 enrolled Universitas Sumatera Utara
RandomizedParallel-groupSingle-blindTreatment

Summary

The compound ACTH4-10Pro8-Gly9-Pro10 is a synthetic analog molecule of an adrenocorticotropic hormone (ACTH) short fragment. That is free from hormonal effects and has neuromodulatory effects. We investigate the neuroprotective effects of ACTH4-10Pro8-Gly9-Pro10 can lessen neurotoxicity against ketamine in neonatal rats by looking at BDNF expression in the cortex and hippocampus tissue as well as BDNF blood levels.

Timeline

Start
2021-08-01
Primary completion
2021-09-30
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ACTH4-10Pro8-Gly9-Pro10 Unknown — —
Comparator Ketamine Small molecule 40 mg/kg Subcutaneous

Indications

No indication recorded.